![]() |
Metastatic breast cancer: AstraZeneca's Faslodex (fulvestrant) approved for new indic
AstraZeneca has announced that the US Food and Drug Administration (FDA) has approved a new indication in the US, expanding the use of Faslodex® (fulvestrant) to include use in combination with...
More... |
| All times are GMT -7. The time now is 08:56 PM. |
Powered by vBulletin® Version 3.8.7
Copyright ©2000 - 2026, vBulletin Solutions, Inc.
Copyright HER2 Support Group 2007 - 2021